Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Mt. Sinai Medical Center New York, United States

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Oregon Health Sciences University Portland, Oregon, United States

View Trial Details

Completed

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

NCT00049296

Conditions: AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003110

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +25 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00028665

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

NCT00027937

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

NCT00410657

Conditions: Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00096096

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +76 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

NCT00317785

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +48 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions